Conference
COMPARISON OF DABIGATRAN VERSUS WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVULAR HEART DISEASE: THE RE-LY® TRIAL
Authors
Ezekowitz MD; Parise H; Nagarakanti R; Noack H; Brueckmann M; Clemens A; Reilly P; Connolly S; Yusuf S; Wallentin L
Volume
63
Publisher
Elsevier
Publication Date
April 2014
DOI
10.1016/s0735-1097(14)60325-9
Conference proceedings
Journal of the American College of Cardiology
Issue
12
ISSN
0735-1097